Identification and Validation of Transcription Factor-driven Enhancers of Genes Related to Lipid Metabolism in Metastatic Oral Squamous Cell Carcinomas

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2022 Apr 16

PMID 35428233

Authors

Liru Zhang

Shuangling Zhao

Yuanhang Liu

Feifei Lv

Xixue Geng

Affiliations

Soon will be listed here.

Abstract

Background: The role and mechanisms of lipid metabolism in oral squamous cell carcinomas (OSCC) metastasis have not been clarified. This study aims to identify lipid metabolism-related genes and transcription factors regulated by metastasis-associated enhancers (MAEs) in OSCC.

Methods: Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA) were performed for lipid metabolism enrichment. TCGA data were used to analyze the differentially expressed lipid metabolism-related genes. MAEs were analyzed using GSE120634. Overlapping analysis was used to screen the MAE-regulated lipid metabolism-related genes, and the prognosis of these genes was analyzed. Transcription factor prediction was performed for the MAE-regulated lipid metabolism-related genes with prognostic value. Validation of the metastatic specificity of MAEs at ACAT1, OXSM and VAPA locus was performed using GSE88976 and GSE120634. ChIP-qPCR, qRT-PCR and Western blotting were used to verify the regulation of ACAT1, OXSM and VAPA expression by CBFB. Effects of CBFB knockdown on proliferation, invasion and lipid synthesis in metastatic OSCC cells were analyzed.

Results: Lipid metabolism was significantly enhanced in metastatic OSCC compared to non-metastatic OSCC. The expression of 276 lipid metabolism-related genes was significantly upregulated in metastatic OSCC, which were functionally related to lipid uptake, triacylglycerols, phospholipids and sterols metabolism. A total of 6782 MAEs and 176 MAE-regulated lipid metabolism-related genes were filtered. Three MAE-regulated lipid metabolism-related genes, ACAT1, OXSM and VAPA, were associated with a poor prognosis in OSCC patients. Enhancers at ACAT1, OXSM and VAPA locus were metastasis-specific enhancers. CBFB regulated ACAT1, OXSM and VAPA expression by binding to the enhancers of these genes. Knockdown of CBFB inhibited proliferation, invasion and lipid synthesis in metastatic OSCC cells.

Conclusion: The MAE-regulated lipid metabolism-related genes (ACAT1, OXSM and VAPA) and the key transcription factor (CBFB) were identified. CBFB knockdown inhibited proliferation, invasion and lipid synthesis of OSCC cells. These findings provide novel candidates for the development of therapeutic targets for OSCC.

Citing Articles

Identification biomarkers and therapeutic targets of disulfidptosis-related in rheumatoid arthritis via bioinformatics, molecular dynamics simulation, and experimental validation.

Xu B, Zhang H, Shen B, Wu J, Shi M, Li X Sci Rep. 2025; 15(1):8779.

PMID: 40082645 PMC: 11906621. DOI: 10.1038/s41598-025-93656-4.

Inhibition of triglyceride metabolism-associated enhancers alters lipid deposition during adipocyte differentiation.

Zeng S, Li Z, Li X, Du Q, Zhang Y, Zhong Z FASEB J. 2025; 39(2):e70347.

PMID: 39873971 PMC: 11774232. DOI: 10.1096/fj.202401137R.

Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma.

Gupta I, Badrzadeh F, Tsentalovich Y, Gaykalova D J Exp Clin Cancer Res. 2024; 43(1):239.

PMID: 39169426 PMC: 11337877. DOI: 10.1186/s13046-024-03141-5.

A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.

Hu G, Yao H, Wei Z, Li L, Yu Z, Li J Sci Rep. 2023; 13(1):12403.

PMID: 37524774 PMC: 10390519. DOI: 10.1038/s41598-023-39563-y.

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma.

Zhang D, Zhang X, Liu Z, Han T, Zhao K, Xu X Front Oncol. 2023; 13:1207068.

PMID: 37427103 PMC: 10327293. DOI: 10.3389/fonc.2023.1207068.

References

Joseph J, Harishankar M, Pillai A, Devi A . Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol. 2018; 80:23-32. DOI: 10.1016/j.oraloncology.2018.03.004. View

Cheng C, Geng F, Cheng X, Guo D . Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018; 38(1):27. PMC: 5993136. DOI: 10.1186/s40880-018-0301-4. View

Gu L, Zhu Y, Lin X, Tan X, Lu B, Li Y . Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. 2020; 39(11):2437-2449. DOI: 10.1038/s41388-020-1156-0. View

Malik N, Yan H, Moshkovich N, Palangat M, Yang H, Sanchez V . The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription. Nat Commun. 2019; 10(1):2071. PMC: 6502810. DOI: 10.1038/s41467-019-10102-6. View

Luo C, Zhang J, Zhang Y, Zhang X, Chen Y, Fan W . Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma. Cell Cycle. 2020; 19(15):1983-1993. PMC: 7469679. DOI: 10.1080/15384101.2020.1786633. View

Cronin K, Lake A, Scott S, Sherman R, Noone A, Howlader N . Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer. 2018; 124(13):2785-2800. PMC: 6033186. DOI: 10.1002/cncr.31551. View

Yoon D, Bae K, Kim J, Choi Y, Yoon K . Oncogenic Effect of the Novel Fusion Gene in Lung Adenocarcinoma. Int J Mol Sci. 2019; 20(9). PMC: 6539523. DOI: 10.3390/ijms20092309. View

Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z . Lipid metabolism and cancer. J Exp Med. 2021; 218(1). PMC: 7754673. DOI: 10.1084/jem.20201606. View

Arellano-Garcia M, Li R, Liu X, Xie Y, Yan X, Loo J . Identification of tetranectin as a potential biomarker for metastatic oral cancer. Int J Mol Sci. 2010; 11(9):3106-21. PMC: 2956083. DOI: 10.3390/ijms11093106. View

10.

SantAnna-Silva A, Santos G, Campos S, Oliveira Gomes A, Perez-Valencia J, Rumjanek F . Metabolic Profile of Oral Squamous Carcinoma Cell Lines Relies on a Higher Demand of Lipid Metabolism in Metastatic Cells. Front Oncol. 2018; 8:13. PMC: 5801303. DOI: 10.3389/fonc.2018.00013. View

11.

Sze C, Shilatifard A . MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer. Cold Spring Harb Perspect Med. 2016; 6(11). PMC: 5088509. DOI: 10.1101/cshperspect.a026427. View

12.

Park J, Coffey N, Limoges A, Le A . The Heterogeneity of Lipid Metabolism in Cancer. Adv Exp Med Biol. 2018; 1063:33-55. DOI: 10.1007/978-3-319-77736-8_3. View

13.

Miguel A, Mello F, Melo G, Rivero E . Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis. Head Neck. 2019; 42(3):569-584. DOI: 10.1002/hed.26009. View

14.

Menendez J, Lupu R . Fatty acid synthase (FASN) as a therapeutic target in breast cancer. Expert Opin Ther Targets. 2017; 21(11):1001-1016. DOI: 10.1080/14728222.2017.1381087. View

15.

Rohrig F, Schulze A . The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016; 16(11):732-749. DOI: 10.1038/nrc.2016.89. View

16.

Okazaki K, Anzawa H, Liu Z, Ota N, Kitamura H, Onodera Y . Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers. Nat Commun. 2020; 11(1):5911. PMC: 7679411. DOI: 10.1038/s41467-020-19593-0. View

17.

Jin X, Demere Z, Nair K, Ali A, Ferraro G, Natoli T . Publisher Correction: A metastasis map of human cancer cell lines. Nature. 2021; 599(7885):E7. PMC: 8599020. DOI: 10.1038/s41586-021-04149-z. View

18.

Santos M, Rappa G, Karbanova J, Kurth T, Corbeil D, Lorico A . VAMP-associated protein-A and oxysterol-binding protein-related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum. J Biol Chem. 2018; 293(36):13834-13848. PMC: 6130944. DOI: 10.1074/jbc.RA118.003725. View

19.

Li H, Feng Z, He M . Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells. Theranostics. 2020; 10(16):7053-7069. PMC: 7330842. DOI: 10.7150/thno.41388. View

20.

Lu Y, Zheng Z, Yuan Y, Pathak J, Yang X, Wang L . The Emerging Role of Exosomes in Oral Squamous Cell Carcinoma. Front Cell Dev Biol. 2021; 9:628103. PMC: 7951141. DOI: 10.3389/fcell.2021.628103. View